logo linkedin

Arti­cles:

  1. PUDDU P.E., SALLE L., GER­ARD J.L., ROUET R., DUCROQ J. (2012). IKs block­ade in bor­der zone arrhyth­mias from guinea-​pig ven­tric­u­lar myocardium sub­mit­ted to sim­u­lated ischemia and reper­fu­sion. Fund. Clin. Phar­ma­col. 26 (4) : 44553. link

  1. PUDDU P.E., LEGRAND J.C., SALLE L., ROUET R., DUCROQ J. (2011). IKr vs. IKs block­ade and arrhyth­mo­genic­ity in nor­moxic rab­bit Purk­inje fibers: does it really makes the dif­fer­ence ? Fund. Clin. Phar­ma­col. 25 (3) : 30412. link

  1. DUCROQ J., MOHA OU MAATI H., GUIL­BOT S., DILLY S., LAEM­MEL E., PONS-​HIMBERT C., FAIVRE J.F., BOIS P., STUCKER O., LE GRAND M. (2010). Dexra­zox­ane pro­tects the heart from acute doxorubicin-​induced QT pro­lon­ga­tion : a key role for IKs. Br. J. Phar­ma­col.159 : 93101. link

  1. DUCROQ J., PRINT­EMPS R., GUIL­BOT S., GARDETTE J, SAL­VE­TAT C., LE GRAND M. (2007). Action poten­tial exper­i­ments com­plete hERG assay and QT-​interval mea­sure­ments in car­diac pre­clin­i­cal stud­ies. J. Phar­ma­col Tox­i­col Meth­ods.56: 15970. link

  1. DUCROQ J., ROUET R., SALLE L., PUDDU P.E., REPESSE Y., GHADAN­FAR M., DUCOURET P., GER­ARD J.L. (2006). Class III effects of dofetilide and arrhyth­mias are mod­u­lated by [K+]o in an in vitro model of simulated-​ischemia and reper­fu­sion in guinea-​pig ven­tric­u­lar myocardium. Eur. J. Phar­ma­col.532: 27989. link

  1. DUCROQ J., ROUET R., PUDDU P.E., SALLE L., TABOUREL C., DUCOURET P., GER­ARD J.L. (2005). Elec­tro­phys­i­o­log­i­cal effects of azim­ilide in an in vitro model of simulated-​ischemia and reper­fu­sion in guinea-​pig ven­tric­u­lar myocardium. Eur. J. Phar­ma­col.518: 16574. link

  1. DUCROQ J., PRINT­EMPS R., LE GRAND M. (2005). Addi­tive effects of ziprasi­done and D,L-sotalol on the action poten­tial in rab­bit Purk­inje fibres and on the hERG potas­sium cur­rent. J. Phar­ma­col Tox­i­col Meth­ods.52: 11522. link